通过适度电场调节SARS-CoV-2尖端蛋白反应性:通往创新疗法的途径
Thi-Huong Nguyen1,2, Hanqing Wang1,2, Li-Yu Chen1,3,4
1Institute for Bioprocessing and Analytical Measurement Techniques, 37308 Heilbad Heiligenstadt, Germany.
ACS omega
|December 11, 2023
概括
将电场应用于SARS-CoV-2尖端蛋白显著降低了它与人体细胞的结合能力. 这种物理方法改变了蛋白质结构,为抗击COVID-19及其变种提供了一种新的方法.
科学领域:
- 生物物理学的生物物理.
- 病毒学 病毒学
- 材料科学 材料科学 材料科学
背景情况:
- 传统的生物化学方法用于COVID-19治疗面临的挑战是病毒突变.
- 模拟表明外部电场 (E-fields) 可以减少SARS-CoV-2尖端蛋白的结合.
- 关于电子场对尖蛋白结构和功能的影响的实证数据有限.
研究的目的:
- 为了研究低/中等强度E场暴露对SARS-CoV-2尖端蛋白与ACE2受体结合的影响.
- 在E-field处理后,对尖端蛋白的结构变化进行表征.
- 探索减轻病毒反应性的非生物化学策略.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 和石英晶微平衡 (QCM) 实验,以评估结合能力.
- 动态光散射 (DLS) 用于测量表面的泽塔潜力并确认结构重排.
- 循环二重化 (CD) 光谱法用于分析二次蛋白质结构的变化.
主要成果:
- 在E-field治疗后,SARS-CoV-2尖端蛋白与ACE2的结合能力显著降低.
- 电场暴露诱导了显著的蛋白质结构重组,由增强的负面泽塔潜力证明.
- CD光谱学证实了二次蛋白质结构的变化,表明了分子变化.
结论:
- 电场应用是一种可行的物理策略,可以修改SARS-CoV-2尖端蛋白结构并降低其结合亲和力.
- 这种方法为开发针对当前和未来COVID-19变种的创新,非生物化学治疗和预防策略提供了潜力.
- 对E场与病毒蛋白相互作用的进一步研究可能会为传染病控制开辟新的途径.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.